Compound Q&A
What is the market or research trend for Ganetespib (CAS: 888216-25-9)?
Answer
Research on Ganetespib (CAS: 888216-25-9) is focused on its potential as an antifibrotic and anticancer agent. Recent trends show a growing interest in its use for treating idiopathic pulmonary fibrosis and solid tumors. Market demand is increasing due to its promising clinical outcomes and ongoing clinical trials. However, cost and regulatory hurdles remain significant challenges to widespread adoption.
About
CAS No
888216-25-9
English Name
Ganetespib
Molecular Formula
C20H20N4O3
Molecular Weight
364.41 g/mol
SMILES
CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)O
InChIKey
RVAQIUULWULRNW-UHFFFAOYSA-N
Last Updated: 2025-09-26 14:59
